{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:09Z","timestamp":1786989009029,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.euroneuro.2003.08.009","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T07:58:31Z","timestamp":1069401511000},"page":"469-475","source":"Crossref","is-referenced-by-count":57,"title":["Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment"],"prefix":"10.1016","volume":"13","author":[{"given":"Barbara J.","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2003.08.009_BIB1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy of outpatient alcoholics: results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00004714-200102000-00013","article-title":"Posttreatment results of combining naltrexone and cognitive behavior therapy for the treatment of alcoholism","volume":"21","author":"Anton","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","article-title":"A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence","volume":"27","author":"Balldin","year":"2003","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB5","first-page":"149","article-title":"Acamprosate: multicenter Portuguese efficacy and tolerance evaluation study","volume":"18","author":"Barrias","year":"1997","journal-title":"Psiquiatr. Cl\u0131́n."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1530-0277.1998.tb04295.x","article-title":"Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study","volume":"22","author":"Besson","year":"1998","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence in adults","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/alcalc\/35.2.176","article-title":"United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archpsyc.1997.01830240090013","article-title":"The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group","volume":"54","author":"Croop","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/alcalc\/37.4.375","article-title":"Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?","volume":"37","author":"de Wildt","year":"2002","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1440-1614.2002.01019.x","article-title":"Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?","volume":"36","author":"Feeney","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00004714-200212000-00009","article-title":"Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study","volume":"22","author":"Gastpar","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000259166","article-title":"Acamprosate and prevention of relapse in alcoholics","volume":"3","author":"Geerlings","year":"1997","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/alcalc\/36.5.413","article-title":"Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain","volume":"36","author":"Gual","year":"2001","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB15","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1530-0277.2002.tb02682.x","article-title":"A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial","volume":"26","author":"Guardia","year":"2002","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","article-title":"Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial","volume":"21","author":"Heinala","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.jcp.0000084029.22282.bb","article-title":"Dose-randing kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects","volume":"23","author":"Johnson","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining Naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00004714-200112000-00024","article-title":"A preliminary report on possible naltrexone and nonsteroidal analgesic interactions","volume":"21","author":"Kim","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0893-133X(99)00135-9","article-title":"Naltrexone vs. nefazodone for treatment of alcohol dependence: a placebo-controlled trial","volume":"22","author":"Kranzler","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB21","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa011127","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"345","author":"Krystal","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB22","first-page":"182","article-title":"Acamprosate: a stabilising factor in long-term withdrawal of alcoholic patients","volume":"50","author":"Ladewig","year":"1993","journal-title":"Ther. Umsch."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5694\/j.1326-5377.2002.tb04550.x","article-title":"Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting","volume":"176","author":"Latt","year":"2002","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB24","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(85)91615-0","article-title":"Ability of calcium acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics","volume":"1","author":"Lhuintre","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/oxfordjournals.alcalc.a045057","article-title":"Acamprosate appears to decrease alcohol intake in weaned alcoholics","volume":"25","author":"Lhuintre","year":"1990","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0893-133X(02)00368-8","article-title":"A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone","volume":"27","author":"Mason","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB27","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1360-0443.2001.961115654.x","article-title":"Naltrexone for alcohol dependence: a randomized controlled trial","volume":"96","author":"Morris","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence: a controlled study","volume":"49","author":"O'Malley","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.1996.01830030039007","article-title":"Six-month follow-up of naltrexone and psychotherapy for alcohol dependence","volume":"53","author":"O'Malley","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00019442-199700540-00007","article-title":"Naltrexone as an adjunctive treatment for older patients with alcohol dependence","volume":"5","author":"Oslin","year":"1997","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB31","first-page":"239","article-title":"Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol","volume":"30","author":"Paille","year":"1995","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB32","series-title":"Novel Pharmacological Interventions for Alcoholism","first-page":"348","article-title":"Calcium acetyl homotaurinate for maintaining abstinence in weaned alcoholic patients: a placebo controlled double-blind multi-centre study","author":"Pelc","year":"1992"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1192\/bjp.171.1.73","article-title":"Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients","volume":"170","author":"Pelc","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB34","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1530-0277.2002.tb02452.x","article-title":"The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependence patients with a statistical modeling of therapy success prediction","volume":"26","author":"Pelc","year":"2002","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1360-0443.1997.tb02873.x","article-title":"Acamprosate treatment in a long-term community-based alcohol rehabilitation programme","volume":"92","author":"Poldrugo","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB36","first-page":"65","article-title":"Does acamprosate diminish the appetite for alcohol in weaned alcoholics","volume":"51","author":"Rousseaux","year":"1996","journal-title":"J. Pharm. Belg."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00003088-199835050-00001","article-title":"Clinical pharmacokinetics of acamprosate","volume":"35","author":"Saivin","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archpsyc.1996.01830080023006","article-title":"Relapse prevention by acamprosate: results from a placebo controlled study in alcohol dependence","volume":"53","author":"Sass","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/alcalc\/35.2.202","article-title":"Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study","volume":"35","author":"Tempesta","year":"2000","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB40","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","article-title":"Naltrexone and alcohol dependence: role of subject compliance","volume":"54","author":"Volpicelli","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2003.08.009_BIB42","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(96)91682-7","article-title":"Comparison of acamprosate and placebo in long-term treatment of alcohol dependence","volume":"347","author":"Whitworth","year":"1996","journal-title":"Lancet"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X03001822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X03001822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T10:11:58Z","timestamp":1682590318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X03001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0924977X03001822"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2003.08.009","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}